Dipna Pharmachem Ltd - Stock Valuation and Financial Performance

BSE: 543594 | NSE: | Trading | Small Cap

Dipna Pharma. Share Price

9.37 -0.26 -2.70%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Dipna Pharma.

M-Cap below 100cr DeciZen not available

Dipna Pharmachem stock performance -

mw4me loader
P/E Ratio (SA):
26.33
Market Cap:
24 Cr.
52-wk low:
8.2
52-wk high:
24.1

Is Dipna Pharmachem Ltd an attractive stock to invest in?

1. Is Dipna Pharmachem Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dipna Pharmachem Ltd is a below average quality company.

2. Is Dipna Pharmachem Ltd undervalued or overvalued?

The key valuation ratios of Dipna Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Dipna Pharmachem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dipna Pharmachem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Dipna Pharma.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dipna Pharmachem Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 5.4%6.6%4.4%2.4%13.2%6.5%-
Value Creation
Index
-0.6-0.5-0.7-0.8-0.1-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 16.620.230.53172.899.9100
Sales YoY Gr.-21.9%51.3%1.5%134.7%37.3%-
Adj EPS 3.554.41.257.10.60.4
YoY Gr.-43.4%-12.8%-72.9%4736.4%-98.9%-
BVPS (₹) 22.323.926.8288516.715
Adj Net
Profit
0.10.10.101.20.91
Cash Flow from Ops. 00-3.1-2.42.8-21-
Debt/CF from Ops. 00-3.1-5.13.6-0.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA43.3%48.5%37.3%
Adj EPS NA-29%-47.5%-98.9%
BVPSNA-5.6%-14.5%-80.3%
Share Price - - - -1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
15.621.617.24.310172.3
Op. Profit
Mgn %
2.42.91.61.33.12.5NAN
Net Profit
Mgn %
0.40.50.30.11.60.90.9
Debt to
Equity
11.212.317.521.75.90.7-
Working Cap
Days
02231922521521970
Cash Conv.
Cycle
0748311547490

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 48.46%

Debt to equity has declined versus last 3 years average to 0.65

Return on Equity has declined versus last 3 years average to 2.30%

Net Profit has been subdued in last 3 years -47.48%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Dipna Pharmachem Ltd.

Standalone Consolidated
TTM EPS (₹) 0.4 -
TTM Sales (₹ Cr.) 99.9 -
BVPS (₹.) 15 -
Reserves (₹ Cr.) 12 -
P/BV 0.64 -
PE 26.33 -
From the Market
52 Week Low / High (₹) 8.22 / 24.12
All Time Low / High (₹) 8.22 / 27.61
Market Cap (₹ Cr.) 24
Equity (₹ Cr.) 24.9
Face Value (₹) 10
Industry PE 75.3

Management X-Ray of Dipna Pharma.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Dipna Pharma.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales16.5620.1830.543172.7699.93
Operating Expenses 16.1719.7030.0930.6070.5097.42
Manufacturing Costs1.460.440.080.060.410.04
Material Costs14.1718.5328.9429.5868.5695.49
Employee Cost 0.260.350.380.410.620.45
Other Costs 0.280.370.680.550.911.44
Operating Profit 0.380.480.450.402.262.51
Operating Profit Margin (%) 2.3%2.4%1.5%1.3%3.1%2.5%
Other Income 0.010.010.010.020.010.01
Interest 0.330.430.390.350.691.12
Depreciation 00.010.010.010.010.01
Exceptional Items 000000
Profit Before Tax 0.070.060.060.061.571.38
Tax 0.010.0200.030.410.47
Profit After Tax 0.060.030.060.021.170.91
PAT Margin (%) 0.4%0.2%0.2%0.1%1.6%0.9%
Adjusted EPS (₹)3.01.62.91.257.10.6
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0.460.490.550.571.7424.36
Share Capital 0.040.040.040.040.0411.97
Reserves 0.420.450.510.541.7012.39
Minority Interest000000
Debt5.106.019.5712.4310.1915.91
Long Term Debt003.363.685.8014.18
Short Term Debt5.106.016.218.744.391.73
Trade Payables5.507.538.3111.7823.0336.28
Others Liabilities 0.030.030.010.021.271.01
Total Liabilities 11.0814.0618.4424.7936.2377.56

Fixed Assets

Gross Block0.010.070.070.070.080.09
Accumulated Depreciation0.010.020.030.030.040.05
Net Fixed Assets0.010.050.040.040.040.04
CWIP 000000
Investments 000000
Inventories4.353.345.557.206.3018.94
Trade Receivables68.8511.2014.9526.9728.53
Cash Equivalents 0.300.120.180.250.215.69
Others Assets0.441.711.472.362.7024.35
Total Assets 11.0814.0618.4424.7936.2377.56

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 00-3.12-2.432.81-20.98
PBT 000.060.061.571.38
Adjustment 000.390.350.610.97
Changes in Working Capital 00-3.57-2.821.03-22.86
Tax Paid 000-0.02-0.41-0.47
Cash Flow From Investing Activity 000.010-0.01-0.01
Capex 000-0.01-0.01-0.01
Net Investments 000000
Others 000.010.0100
Cash Flow From Financing Activity 003.172.50-2.8426.47
Net Proceeds from Shares 0000021.71
Net Proceeds from Borrowing 000.510.32-0.368.38
Interest Paid 00-0.39-0.35-0.61-0.96
Dividend Paid 000000
Others 003.052.53-1.88-2.66
Net Cash Flow 000.060.08-0.045.48
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)13.246.7811.394.32101.026.99
ROCE (%)7.167.985.423.5418.169.58
Asset Turnover Ratio1.491.611.881.432.381.76
PAT to CFO Conversion(x)00-52-121.52.4-23.05
Working Capital Days
Receivable Days132134120154105101
Inventory Days966953753446
Payable Days14212810012493113

Dipna Pharmachem Ltd Stock News

Dipna Pharmachem Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Dipna Pharma. on 28-Mar-2024 16:01 is ₹9.37.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Dipna Pharma. stood at ₹24.01.
The latest P/E ratio of Dipna Pharma. as of 28-Mar-2024 16:01 is 26.33.
The latest P/B ratio of Dipna Pharma. as of 28-Mar-2024 16:01 is 0.64.
The 52-week high of Dipna Pharma. is ₹24.12 and the 52-week low is ₹8.22.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dipna Pharma. is ₹99.93 ( Cr.) .

About Dipna Pharmachem Ltd

The company was originally incorporated as “Dipan Pharmachem Private Limited” under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July 19, 2011 bearing Corporate Identification Number issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, the name of company was changed to “Dipna Pharmachem Private Limited” and a fresh certificate of incorporation was issued by Registrar of Companies, Gujarat, Dadra and Nagar Havelli on March 29, 2012. After that, the Company was converted from Private limited to Public Limited company pursuant to a special resolution passed by shareholders at the EGM held on May 13, 2022 and consequently the name of Company was changed as “Dipna Pharmachem Limited” and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022.

The company is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. Presently its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has pan India market for its products. The company had also started the selling of chemicals on commission basis. In the financial year 2022, the company had earned commission income of Rs 127.50 lakh. The company is doing trading in Ahmedabad and surrounding area of Ahmedabad.

Business area of the company

Dipna Pharmachem is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation since 2011. The company’s huge portfolio includes expertise for marketing and sourcing of industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation and intermediates, assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of leading certificates like WHO-GMP.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.